Zhejiang Sunflower Great Health Co., Ltd. (SHE:300111)
3.880
+0.020 (0.52%)
Apr 30, 2026, 3:04 PM CST
SHE:300111 Revenue
Zhejiang Sunflower Great Health had revenue of 54.56M CNY in the quarter ending March 31, 2026, a decrease of -24.46%. This brings the company's revenue in the last twelve months to 253.87M, down -20.40% year-over-year. In the year 2025, Zhejiang Sunflower Great Health had annual revenue of 271.53M, down -17.81%.
Revenue (ttm)
253.87M
Revenue Growth
-20.40%
P/S Ratio
19.57
Revenue / Employee
766.97K
Employees
331
Market Cap
4.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 271.53M | -58.83M | -17.81% |
| Dec 31, 2024 | 330.37M | -8.05M | -2.38% |
| Dec 31, 2023 | 338.42M | 2.56M | 0.76% |
| Jan 1, 2023 | 335.86M | 38.57M | 12.97% |
| Jan 1, 2022 | 297.29M | 10.33M | 3.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.63B |
| Jianmin Pharmaceutical Group | 3.35B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Hunan Fangsheng Pharmaceutical | 1.79B |
| Fuan Pharmaceutical (Group) | 1.74B |
| Bide Pharmatech | 1.32B |
| Beijing Beilu Pharmaceutical | 1.21B |
| Teyi Pharmaceutical Group Co.,Ltd | 924.53M |